CMP vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 22, 2026

CMP

39.4
AI Score
VS
CBT Wins

CBT

46.9
AI Score

Investment Advisor Scores

CMP

39score
Recommendation
SELL

CBT

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CMP CBT Winner
Forward P/E 14.771 9.9404 CBT
PEG Ratio 0.1337 1.0017 CMP
Revenue Growth 0.3% 6.4% CBT
Earnings Growth -91.7% -93.7% CMP
Tradestie Score 39.4/100 46.9/100 CBT
Profit Margin 1.4% 5.2% CBT
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CBT

Relative Price Performance (Last 90 Days)

CMP 1M: -13.1% · 3M: -25.4% CBT 1M: -6.3% · 3M: -11.4%

Current Technical Phase

CMP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.9%), weak momentum, RSI 33

RSI (14): 32.5 · Price: $22.24

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $77.65

Fundamentals Snapshot

Metric CMP CBT
Market Cap — —
Forward P/E 17.2 10.9
Trailing P/E 52.5 21.8
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 0.42 3.53
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.